Literature DB >> 9838100

Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus.

A M Mazarati1, R A Baldwin, R Sankar, C G Wasterlain.   

Abstract

An animal model of self-sustaining status epilepticus (SSSE) induced in rats by brief intermittent perforant path stimulation (PPS) was examined with regard to the effects of two conventional antiepileptic drugs, diazepam and phenytoin. Thirty or sixty minutes PPS induced SSSE characterized by continuous behavioral and electrographic seizures lasting for hours. Both diazepam (10 mg/kg i. v.) and phenytoin (50 mg/kg i.v.) prevented the establishment of SSSE when administered 10 min prior to PPS. The injection of diazepam to seizing animals, 10 min after the end of 30 min PPS, was significantly less effective than pretreatment in attenuating SSSE. Administration of diazepam after 60 min PPS was characterized by a further decrease of its efficacy. Phenytoin was effective in aborting SSSE when injected 10 min after 30 min PPS. However, its efficacy was vastly decreased if injected 40 min after 30 min PPS, or 10 min after 60 min PPS. It is concluded that antiepileptic drugs, while highly effective in blocking the induction of SSSE, failed to affect its maintenance. SSSE induced by PPS is an advantageous animal model of refractory status epilepticus, which may be used in preclinical studies of novel antiepileptic drugs. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9838100     DOI: 10.1016/s0006-8993(98)01080-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  55 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

2.  The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticus.

Authors:  Claude G Wasterlain; Thomas Stöhr; Alain Matagne
Journal:  Epilepsy Res       Date:  2011-01-28       Impact factor: 3.045

Review 3.  Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment.

Authors:  Jerome Niquet; Roger Baldwin; Lucie Suchomelova; Lucille Lumley; David Naylor; Roland Eavey; Claude G Wasterlain
Journal:  Ann N Y Acad Sci       Date:  2016-07-08       Impact factor: 5.691

Review 4.  Continuous electroencephalogram monitoring in the critically ill.

Authors:  John J Wittman; Lawrence J Hirsch
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

5.  Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

Authors:  David E Naylor; Hantao Liu; Claude G Wasterlain
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

6.  Status epilepticus: Danse Macabre in a ballet of subunits.

Authors:  Andrey Mazarati; Raman Sankar
Journal:  Epilepsy Curr       Date:  2006 May-Jun       Impact factor: 7.500

7.  Population pharmacokinetic analysis for simultaneous determination of B (max) and K (D) in vivo by positron emission tomography.

Authors:  Lia C Liefaard; Bart A Ploeger; Carla F M Molthoff; Ronald Boellaard; Adriaan A Lammertsma; Meindert Danhof; Rob A Voskuyl
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

8.  Subunit-specific trafficking of GABA(A) receptors during status epilepticus.

Authors:  Howard P Goodkin; Suchitra Joshi; Zakaria Mtchedlishvili; Jasmit Brar; Jaideep Kapur
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

Review 9.  Refractory and super-refractory status epilepticus--an update.

Authors:  Sara Hocker; William O Tatum; Suzette LaRoche; W David Freeman
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

Review 10.  Treatment of Generalized Convulsive Status Epilepticus in Pediatric Patients.

Authors:  Elizabeth L Alford; James W Wheless; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.